Lectures
Cirrhosis.pptx (sharepoint.com)
Management of Decompensated Cirrhosis - teachIM
Videos
Podcasts
#100: Cirrhosis: Initial Evaluation and Management - The Curbsiders
#101: Cirrhosis: Medications, decompensation, complications - The Curbsiders
Articles
Cirrhosis: Diagnosis and Management | AAFP
References
Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol. 2021;56(7):593-619. doi:10.1007/s00535-021-01788-x
Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(2):1014-1048. doi:10.1002/hep.31884
Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases [published correction appears in Hepatology. 2017 Jul;66(1):304]. Hepatology. 2017;65(1):310-335. doi:10.1002/hep.28906
Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol. 2013;108(9):1458-1463. doi:10.1038/ajg.2013.219
Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071-1081. doi:10.1056/NEJMoa0907893